| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $819,783 ) |
| | 2024 | 2024 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 001 | 1 | NIH | 9/9/2024 | $819,783 |
| | 2024 | 2021 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 000 | 1 | NIH | 9/9/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,113,831 ) |
| | 2023 | 2023 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 000 | 1 | NIH | 8/21/2023 | $1,113,831 |
| | 2023 | 2021 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 001 | 1 | NIH | 8/23/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $832,330 ) |
| | 2022 | 2022 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 003 | 1 | NIH | 9/19/2022 | $832,330 |
| | 2022 | 2021 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 001 | 1 | NIH | 10/26/2021 | $913,614 |
| | 2022 | 2021 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 002 | 1 | NIH | 9/19/2022 | $0 |
| | 2022 | 2021 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 000 | 1 | NIH | 10/22/2021 | -$913,614 |
|
| Issue Date FY: 2021 ( Subtotal = $913,614 ) |
| | 2021 | 2021 | CANCER RESEARCH UK | 2 REDMAN PLACE | LONDON | | | | GBR | OT2CA262137 | Cancer Grand Challenges: Operations Management Application | 000 | 1 | NIH | 5/10/2021 | $913,614 |
|
| Issue Date FY: 2012 ( Subtotal = $7,850 ) |
| | 2012 | 2012 | CANCER RESEARCH UNITED KINGDOM | 61 Lincolns Inn Fields | CAMBRIDGE | | | | GBR | F32AR060166 | POLARIZATION OF ADULT STEM CELLS, THE ROLE OF VANGL IN SKIN HOMEOSTASIS AND CANCE | 002 | 3 | NIH | 9/4/2012 | $7,850 |
|
| Issue Date FY: 2011 ( Subtotal = $7,850 ) |
| | 2011 | 2011 | CANCER RESEARCH UNITED KINGDOM | 61 Lincolns Inn Fields | CAMBRIDGE | | | | GBR | F32AR060166 | POLARIZATION OF ADULT STEM CELLS, THE ROLE OF VANGL IN SKIN HOMEOSTASIS AND CANCE | 000 | 2 | NIH | 8/17/2011 | $7,850 |
|
| Issue Date FY: 2010 ( Subtotal = $7,850 ) |
| | 2010 | 2010 | CANCER RESEARCH UNITED KINGDOM | 61 Lincolns Inn Fields | CAMBRIDGE | | | | GBR | F32AR060166 | POLARIZATION OF ADULT STEM CELLS, THE ROLE OF VANGL IN SKIN HOMEOSTASIS AND CANCE | 001 | 1 | NIH | 8/16/2010 | $7,850 |
| | 2010 | 2010 | CAMBRIDGE RESEARCH INSTITUTE | LI KA SHING CENTRE | CAMBRIDGE | | | | GBR | F32AR060166 | POLARIZATION OF ADULT STEM CELLS, THE ROLE OF VANGL IN SKIN HOMEOSTASIS AND CANCE | 003 | 1 | NIH | 9/14/2010 | $0 |
|
|
